Participants in clinical trials undergo thorough screening to ensure safety, including psychiatric and cardiovascular evaluations. The preparation phase emphasizes building a rapport with guides and understanding the unique, variable experiences associated with psychedelics. This approach allows individuals, even those without diagnosable issues, to confront underlying human experiences during their psychedelic journey.